News Conference News EAS 2021 For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short Michael O'Riordan June 03, 2021
News Conference News SCAI 2021 In African-American Patients, Nontraditional Risk Factors Track With Early CAD Michael O'Riordan April 28, 2021
News Daily News In Female Veterans With Early ASCVD, Secondary Prevention Falls Short Michael O'Riordan April 21, 2021
News Daily News Highest-Risk Patients Gain the Most From Intensive BP Therapy Todd Neale April 20, 2021
News Daily News Mobile Tech May Boost CAD Secondary Prevention for Older Adults L.A. McKeown April 07, 2021
News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Daily News Pills for Erectile Dysfunction Linked to Fewer CVD Deaths Caitlin E. Cox March 24, 2021
News Daily News Little Improvement Seen Over Two Decades in US Racial Health Disparities L.A. McKeown March 15, 2021
News Daily News ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection Todd Neale March 08, 2021
News Daily News Exercise Outdoes Testosterone at Improving Vascular Function Caitlin E. Cox February 24, 2021
News Daily News Despite COVID-19, Heart Disease Remains Top US Killer: AHA Michael O'Riordan January 28, 2021
News Daily News Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic Michael O'Riordan January 12, 2021
News Features The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations L.A. McKeown December 24, 2020
News Daily News ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show Michael O'Riordan December 21, 2020
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020